# Advanced Instruments to acquire and merge with Nova Biomedical

Advanced Instruments, a subsidiary of Patricia Industries, has agreed to acquire Nova Biomedical. The combined business will operate under the Nova Biomedical name, with combined 2024 sales of $621 million.

- Type: Acquisition
- Announced: 2025-06-02
- Where: United States
- Status: announced
- Products: analytical instruments, reagents, services
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Patricia Industries](https://endata.com/companies/3217.md) (partner)
- [Investor AB](https://endata.com/companies/70640.md) (partner)
- [Advanced Instruments](https://endata.com/companies/83599.md) (acquirer)
- [Nova Biomedical](https://endata.com/companies/83600.md) (target)

## Sources

- [pathologyinpractice.com](https://www.pathologyinpractice.com/story/47785/advanced-instruments-to-acquire-and-merge-with-nova-biomedical), 2025-06-02: "Combining these two great companies aligns with our core strategy to develop and commercialise best-in-class technologies that deliver significant customer value across the biopharma and clinical markets."
- [novabiomedical.com](https://www.novabiomedical.com/nova-merger/), 2025-06-25: "By uniting two organizations with deep scientific heritage and shared values, we are strengthening our ability to deliver the highest standards of quality, innovation, and service you rely on— today and into the future."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.